Which has the lower trailing P/E, INCY or ZTS?

ZTS has the lower trailing P/E: INCY trades at 15.96 and ZTS at 11.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, INCY or ZTS?

Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus ZTS at 5.13%.

Does INCY or ZTS pay a bigger dividend?

ZTS pays a dividend (2.85% yield), while INCY has no payments in the available dividend history.

Is INCY or ZTS more profitable?

INCY runs the higher net margin — INCY at 27.71% versus ZTS at 27.49%.

How have INCY and ZTS total returns compared?

Over the past 10 years, INCY delivered 4.38% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs Zoetis Inc. (ZTS)

A side-by-side comparison of Incyte Corporation and Zoetis Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$25.40B

$125.31HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

ZTS

Zoetis Inc.

$29.95B

$71.45HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

Total return — INCY vs ZTS

growth of $100 · dividends reinvested · last 10y

INCY +52.8% (+4.3%/yr)ZTS +58.8% (+4.7%/yr)ZTS compounded faster over this window

INCY ZTS

INCY vs ZTS: by the numbers

•ZTS is the larger company ($29.95B vs $25.40B market cap).
•ZTS trades at the lower trailing earnings multiple (11.77 vs 15.96 P/E), one valuation lens rather than an overall verdict.
•INCY converts more revenue to profit (27.71% vs 27.49% net margin).
•INCY grew revenue faster over the past five years (16.43% vs 5.13% CAGR).
•ZTS pays a dividend (2.85% yield), while INCY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	INCY	ZTS
P/E ratio	15.96	11.77
Forward P/E	33.31	11.43
P/S ratio	4.36	3.15
P/B ratio	4.00	9.52
EV / EBITDA	11.08	9.42
FCF yield	7.56%	7.90%

Profitability

Metric	INCY	ZTS
Gross margin	92.62%	70.87%
Operating margin	31.57%	37.00%
Net margin	27.71%	27.49%
ROE	25.41%	83.10%
ROIC	22.95%	21.63%

Dividends

Metric	INCY	ZTS
Dividend yield	N/A	2.85%
Payout ratio	N/A	34.43%

Growth (annualized)

Metric	INCY	ZTS
Revenue CAGR (5Y)	16.43%	5.13%
EPS CAGR (5Y)	21.19%	11.88%
FCF CAGR (5Y)	33.69%	6.81%
Total return CAGR (5Y)	11.30%	-17.75%

Frequently asked

Which has the lower trailing P/E, INCY or ZTS?: ZTS has the lower trailing P/E: INCY trades at 15.96 and ZTS at 11.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, INCY or ZTS?: Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus ZTS at 5.13%.
Does INCY or ZTS pay a bigger dividend?: ZTS pays a dividend (2.85% yield), while INCY has no payments in the available dividend history.
Is INCY or ZTS more profitable?: INCY runs the higher net margin — INCY at 27.71% versus ZTS at 27.49%.
How have INCY and ZTS total returns compared?: Over the past 10 years, INCY delivered 4.38% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full ZTS analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio Zoetis P/E ratio Zoetis dividend yield Incyte ROE Zoetis ROE Incyte operating margin Zoetis operating margin Incyte revenue growth Zoetis revenue growth Incyte free cash flow Zoetis free cash flow

Incyte & Zoetis appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.